Relation of Helicobacter pylori infection and multiple sclerosis in Iranian patients

Neurology International

Volumn 5, Issue 2, 2013, Pages 31-33

  Mohebi, Nafiseh ^a   Mamarabadi, Mansoureh ^a   Moghaddasi, Mehdi ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Helicobacter pylori; Immunological influences; Iranian patients; Multiple sclerosis

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

AGE DISTRIBUTION; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE SEVERITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; HELICOBACTER INFECTION; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROLOGICAL COMPLICATION; PATHOGENESIS; PREVALENCE; SEX DIFFERENCE; STATISTICAL ANALYSIS;

EID: 84879527406     PISSN: 20358385     EISSN: 20358377     Source Type: Journal    
DOI: 10.4081/ni.2013.e10     Document Type: Article

References (21)

1. Compston A, Coles A. Multiple sclerosis. Lancet 2010;372:1502-17.
2. Saribas AS, Ozdemir A, Lam C, Safak M. JC virus-induced progressive multifocal leukoencephalopathy. Future Virol 2010;5: 313-23.
3. Compston A, Coles A. Multiple sclerosis. Lancet 2002;359:1221-31
4. Dyment DA, Ebers GC, Sadovnick AD. Genetics of multiple sclerosis. Lancet Neurol 2004;3:104-10.
5. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 2007; 61:288-99.
6. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part II: noninfectious factors. Ann Neurol 2007;61: 504-13.
7. Marrie RA. Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol 2004;3:709-18.
8. Deretzi G, Kountouras J, Gavalas E, et al. Multiple sclerosis and seizures: possible role of Helicobacter pylori. Eur J Neurol 2011;18:e116.
9. Li W, Minohara M, Piao H, et al. Association of anti-Helicobacter pylori neutrophilactivating protein antibody response with anti-aquaporin-4 autoimmunity in Japanese patients with multiple sclerosis and neuromyelitis optica. Mult Scler 2009; 15:1411-21.
10. Pezeshki MZ, Zarrintan S, Zarrintan MH. Helicobacter nanoparticles as a potential treatment of conventional multiple sclerosis. Med Hypotheses 2008;70:122.
11. Mbulaiteye SM, Hisada M, El-Omar EM. Helicobacter pylori associated global gastric cancer burden. Front Biosci 2009; 14:1490-504.
12. Nouraie M, Latifi-Navid S, Rezvan H, et al. Childhood hygienic practice and family education status determine the prevalence of Helicobacter pylori infection in Iran. Helicobacter 2009;14:40-6.
13. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-7.
14. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485-9.
15. Cottrell DA, Kremenchutzky M, Rice GP, et al. The natural history of multiple sclerosis: a geographically based study 5: the clinical features and natural history of primary progressive multiple sclerosis. Brain 1999;122:625-39.
16. Scalfari A, Neuhaus A, Degenhardt A, et al. The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability. Brain 2010; 133:1914-29.
17. Abedini M, Habibi Saravi R, Zarvani A, Farahmand M. Epidemiologic study of multiple sclerosis. J Mazandaran Univ Med Sci 2008;18:82-6.
18. Wender M. [Prevalence of Helicobacter pylori infection among patients with multiple sclerosis]. Neurol Neurochir Pol 2003;37:45-8. [Article in Polish].
19. Latif AH, Shami SK, Batchoun R, et al. Helicobacter pylori: a Jordanian study. Postgrad Med J 1991;67:994-8.
20. Cremonini F, Gasbarrini A. Atopy, Helicobacter pylori and the hygiene hypothesis. Eur J Gastroenterol Hepatol 2003;15:635-6.
21. Li W, Minohara M, Su JJ, et al. Helicobacter pylori infection is a potential protective factor against conventional multiple sclerosis in the Japanese population. J Neuroimmunol 2007;184:227-31.